Visentin, A. and Trentin, L. (2021) “Response to ‘Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2021.280199.